Journal of Hypertension

Journal Logo

July 2023 - Volume 41 - Issue 7

  • Anthony M. Heagerty
  • 0263-6352
  • 1473-5598
  • 12 issues / year
  • 23 of 67 Peripheral Vascular Disease
  • 4.776
Featured Podcast
audioplayer icon

Health football beats them all -subgroup analysis of the 3F- (fit & fun with football) study on white coat hypertension, sustained hypertension, dippers, non-dippers, and on pharmacologically un-/treated arterial hypertension

With the flurry of interest around the World Cup, it’s only right that we discuss the health benefits of football. Join Bastian Shrader and Charis Conradi as they discuss their paper on the benefits of health football in different hypertensive cohorts.

Featured Podcast
audioplayer icon

Cuffless blood pressure measuring devices: ESH Working Group on Blood Pressure Monitoring and Cardiovascular Variability – with George Stergiou

The Journal of Hypertension podcasts speaks to George Stergiou from the University of Athens. His recent publication is a consensus document from the European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring and Cardiovascular Variability.


2021 ESH practice guidelines

This European Society of Hypertension 

statement aims to summarise the 

essential recommendations for blood 

pressure measurements for clinical ​

practice in and out of the office.​​​


​​​​​


BLOOD PRESSURE VARIABILITY

This ESH Consensus paper contributes to a better standardization of future studies on BPV, and provides clinicians with some indications on how BPV can be managed based on currently available data. J Hypertens 2023; 41: 527-544.​​

​​

​​​​​​​​​​​​​​​


C​UFFLESS BLOOD PRESSURE
​MEASURING

Cuffless blood pressure measuring 

devices: review and statement by the 

European Society of Hypertension

Working Group on Blood Pressure 

Monitoring and Cardiovascular 

Variability. 

​​ ​​​ ​


BEDTIME DOSING OF ANTIHYPERTENSIVE MEDICINES

Systematic review and consensus 

statement by the International Society 

​of Hypertension, and endorsed by 

World Hypertension League and ​

European Society of Hypertension. J

Hypertens 2022; 40:1847-1858.


​​​​​​​​​​​​​


podcast series

​Enjoy our podcast series – from the  

benefits of football and more.​​


​​​​​


ISH KYOTO CONFERENCE 2022

FREE ACCESS. Abstracts from the meeti​ng of​ the Int​erna​tional Society of​ Hypertension, 12-16 October 2022, Kyoto. J Hypertens 2023; 41, e1-e512, Suppl 1


​​​​


ESH Conference 2023

Abstracts from the meeting of the  

European Society of Hypertension, 23-

26 June 2023, Milan.

June 2023 - Volume 41 - Suppl 3

 


​​2023 InaSH MEETING ABSTRACTS

​​The 16th Indonesian Soc​iety of  ​

Hypertension meeting abstracts. ​

J Hypertens 2023; 41 (Suppl 2).​​


Latest Articles

Oral Session: BLOOD PRESSURE MEASUREMENT

UNDERSTANDING MEASUREMENT OF POSTURAL HYPOTENSION: A NATIONWIDE SURVEY OF PRIMARY CARE PRACTICE IN ENGLAND

McDonagh, Sinead; Cross, Rosina; Masoli, Jane; More

Oral Session: BLOOD PRESSURE MEASUREMENT

WHICH SYSTOLIC BLOOD PRESSURE SHOWS CLOSEST ASSOCIATIONS WITH LEFT VENTRICULAR MASS? THE INTERNATIONAL 24 HOUR AORTIC BLOOD PRESSURE CONSORTIUM (I24ABC)

Danninger, Kathrin; Weber, Thomas; Wassertheurer, Siegfried; More

Oral Session: BLOOD PRESSURE MEASUREMENT

THRESHOLDS FOR WHITE-COAT AND MASKED BLOOD PRESSURE EFFECTS: AN AMBULATORY BLOOD PRESSURE MONITORING STUDY

Pont, Christian Dal; Feitosa, Audes D. M.; Viana, Gustavo M.; More

Oral Session: BLOOD PRESSURE MEASUREMENT

DASH VS. MEDITERRANEAN DIET ON A SALT RESTRICTION BACKGROUND IN ADULTS WITH HIGH NORMAL BLOOD PRESSURE OR GRADE 1 HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL

Filippou, Christina; Thomopoulos, Costas; Konstantinidis, Dimitrios; More

Oral Session: BLOOD PRESSURE TREATMENT THRESHOLDS AND TARGETS

SEX DIFFERENCES IN INDIVIDUALS WITH OFFICE HIGH NORMAL BLOOD PRESSURE WHO DEVELOPED HYPERTENSION IN 3-YEAR FOLLOW-UP

Kalos, Theodoros; Dimitriadis, Kyriakos; Konstantinidis, Dimitrios; More

Oral Session: BLOOD PRESSURE TREATMENT THRESHOLDS AND TARGETS

DEFICIENCY OF COMPLEMENT C3A AND C5A RECEPTORS DOES NOT PREVENT ANGIOTENSIN II–INDUCED HYPERTENSION AND HYPERTENSIVE END ORGAN DAMAGE

Dreher, Leonie; Bode, Marlies; Herrnstadt, Georg Rudolf; More

Oral Session: BLOOD PRESSURE TREATMENT THRESHOLDS AND TARGETS

CARDIOVASCULAR RISK IN TREATED HYPERTENSIVE PATIENTS WITH ISOLATED DIASTOLIC HYPERTENSION AND ISOLATED LOW DIASTOLIC BLOOD PRESSURE

Chang, Wei -Lun; Chen, Ying -Fan; Chuang, Shao -Yuan; More

Oral Session: BLOOD PRESSURE TREATMENT THRESHOLDS AND TARGETS

ANTIHYPERTENSIVE TREATMENT EVALUATION IN A MULTIMORBIDITY AND POLYPHARMACY TRIAL (ATEMPT): A RANDOMISED CONTROLLED TRIAL

Rahimi, Kazem; Majert, Jeannette; Nazarzadeh, Milad; More

Oral Session: BLOOD PRESSURE VARIABILITY

ASSOCIATIONS OF LONG-TERM VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY WITH SUBCLINICAL KIDNEY DAMAGE AND ALBUMINURIA IN ADULTHOOD: A 30-YEAR PROSPECTIVE COHORT STUDY

Wang, Yang; Zhao, Peng; Chu, Chao; More

Oral Session: BLOOD PRESSURE VARIABILITY

DETERMINANTS OF WITHIN-VISIT OFFICE BLOOD PRESSURE VARIABILITY AND INSTABILITY: EUROPEAN DATA FROM 1.053 INDIVIDUALS

Theodosiadi, Aikaterini; Kollias, Anastasios; Ntineri, Angeliki; More

Oral Session: BLOOD PRESSURE VARIABILITY

SHORT TERM 24HOUR VARIABILITY OF BOTH BRACHIAL AND AORTIC BLOOD PRESSURE IS INCREASED IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASE

Anyfanti, Panagiota; Triantafyllou, Areti; Margouta, Anastasia; More

Oral Session: BLOOD PRESSURE VARIABILITY

ASSOCIATION BETWEEN NOCTURNAL VARIATION IN BLOOD PRESSURE AND RISK OF ACUTE ISCHEMIC STROKE: A SYSTEMATIC REVIEW

Ztriva, Eleftheria; Daios, Stylianos; Kachtsidis, Vasileios; More

Oral Session: CARDIOVASCULAR ONCOLOGY

PATIENTS WITH VERY HIGH RISK OF CARDIOVASCULAR ADVERSE EVENTS DURING CARFILZOMIB THERAPY: PREVENTION AND MANAGEMENT OF EVENTS IN A SINGLE CENTER EXPERIENCE

Mingrone, Giulia; Astarita, Anna; Colomba, Anna; More

Oral Session: CEREBROVASCULAR DISEASES, COGNITIVE DYSFUNCTION AND DEMENTIA

CUMULATIVE BLOOD PRESSURE LOAD AND INCIDENT DEMENTIA, COGNITIVE FUNCTION, AND ALL-CAUSE AND CARDIOVASCULAR DEATHS IN ADULTS AGED 70 YEARS AND OLDER

Xu, Xiaoyue; Catts, Vibeke; Harris, Katie; More

Oral Session: CO-MORBIDITIES IN HYPERTENSION

LONG-TERM EVENT RATES, RISK FACTORS, AND TREATMENT PATTERN IN PATIENTS QUALIFYING FOR DUAL BLOOD PRESSURE-LOWERING THERAPY: AN OBSERVATIONAL STUDY IN 1.4 MILLION INDIVIDUALS

Coca, Antonio; Borghi, Claudio; Stergiou, George S.; More

Oral Session: CO-MORBIDITIES IN HYPERTENSION

SERUM ACID URIC AND HYPERTRIGLYCERIDEMIA AND CAROTID PLAQUES: A SUB-ANALYSIS OF THE URIC ACID RIGHT FOR HEART HEALTH (URRAH) STUDY

Muiesan, Maria Lorenza; Paini, Anna; Rosei, Claudia Agabiti; More

Oral Session: COVID-19 AND CARDIOVASCULAR DISEASE

ONGOING ANTI-HYPERTENSIVE TREATMENT DOESN’T IMPACT ON OUTCOME ON MEDIUM-LONG TERM SEQUELAE OF PATIENTS WITH MODERATE TO SEVERE COVID-19 PNEUMONIA

Cattaneo, Chiara; Salvotti, Francesca; Leidi, Francesca; More

Oral Session: COVID-19 AND HYPERTENSION

THE IMPACT OF COVID-19 PANDEMIC ON BLOOD PRESSURE CONTROL IN PATIENTS WITH TREATED HYPERTENSION. RESULTS OF EUROPEAN SOCIETY OF HYPERTENSION STUDY (ESH ABPM COVID-19 STUDY)

Wojciechowska, Wiktoria; Rajzer, Marek; Weber, Thomas; More

Oral Session: ENDOCRINE HYPERTENSION

UNILATERALLY SELECTIVE ADRENAL VEIN SAMPLING FOR IDENTIFICATION OF SURGICALLY CURABLE PRIMARY ALDOSTERONISM

Rossi, Gian Paolo; Bagordo, Domenico; Amar, Laurence; More

Oral Session: ENDOCRINE HYPERTENSION

SALT RESTRICTION COMBINED WITH RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKADE IS A POTENT ANTIHYPERTENSIVE STRATEGY IN PATIENTS WITH PRIMARY ALDOSTERONISM

Schneider, Holger; Sarkis, Anna -Lina; Sturm, Lisa; More

Oral Session: ENDOTHELIUM AND ATHEROSCLEROSIS

VASCULAR FUNCTION AS POSSIBLE MARKER OF FUTURE SUSTAINED HYPERTENSION IN YOUNG TO-MIDDLE AGE STAGE I HYPERTENSIVES ACCORDING TO DIFFERENT HYPERTENSION SUBTYPES

Saladini, Francesca; Rattazzi, Marcello; Mos, Lucio; More